BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.96B |
| 2 |
Coupang
CPNG
|
+$1.77B |
| 3 |
Amazon
AMZN
|
+$1.55B |
| 4 |
International Flavors & Fragrances
IFF
|
+$1.19B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$1.46B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.39B |
| 3 |
DuPont de Nemours
DD
|
+$948M |
| 4 |
Alibaba
BABA
|
+$860M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$852M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.79% |
| 2 | Healthcare | 13.36% |
| 3 | Financials | 12.86% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
2526
Seritage Growth Properties
SRG
$128M
| $58.1M | ﹤0.01% |
3,168,788
+271,388
| +9% | +$5.03M |
|
|
SP
2527
DELISTED
SP Plus Corporation
SP
| $57.9M | ﹤0.01% |
1,765,713
+52,541
| +3% | +$1.7M |
|
2528
Independent Bank Corp
IBCP
$854M
| $57.6M | ﹤0.01% |
2,436,469
+286,515
| +13% | +$6.07M |
|
2529
Sumitomo Mitsui Financial
SMFG
$167B
| $57.6M | ﹤0.01% |
7,940,333
+7,938,942
| +570,736% | +$55.3M |
|
|
BCOV
2530
DELISTED
Brightcove, Inc.
BCOV
| $57.2M | ﹤0.01% |
2,845,161
+36,430
| +1% | +$731K |
|
|
UMH
2531
UMH Properties
UMH
$1.42B
| $57.2M | ﹤0.01% |
2,981,562
+67,840
| +2% | +$1.14M |
|
|
ALX
2532
Alexander's
ALX
$1.4B
| $57M | ﹤0.01% |
205,519
-1,365
| -0.7% | -$379K |
|
|
ICPT
2533
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $56.9M | ﹤0.01% |
2,466,443
-31,965
| -1% | -$891K |
|
2534
iShares Core S&P US Growth ETF
IUSG
$34B
| $56.7M | ﹤0.01% |
624,675
+29,895
| +5% | +$2.69M |
|
|
IGMS
2535
DELISTED
IGM Biosciences
IGMS
| $56.7M | ﹤0.01% |
739,045
+17,691
| +2% | +$1.61M |
|
|
LMACU
2536
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $56.6M | ﹤0.01% |
+5,289,399
| New | +$64.5M |
|
|
FFIC
2537
DELISTED
Flushing Financial
FFIC
| $56.6M | ﹤0.01% |
2,668,193
+368,456
| +16% | +$7.61M |
|
2538
Academy Sports + Outdoors
ASO
$3.03B
| $56.6M | ﹤0.01% |
2,096,248
+1,039,646
| +98% | +$24.9M |
|
2539
CNA Financial
CNA
$13.8B
| $56.5M | ﹤0.01% |
1,266,059
+141,130
| +13% | +$6.02M |
|
2540
Nurix Therapeutics
NRIX
$2.82B
| $56.5M | ﹤0.01% |
1,816,689
+646,715
| +55% | +$24.5M |
|
|
GWPH
2541
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $56.3M | ﹤0.01% |
259,600
-7,925
| -3% | -$1.49M |
|
2542
Constellium
CSTM
$3.95B
| $56M | ﹤0.01% |
3,811,074
-753,649
| -17% | -$10.8M |
|
|
ELAT
2543
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $56M | ﹤0.01% |
1,219,740
-31,818
| -3% | -$1.53M |
|
|
AFMD
2544
DELISTED
Affimed
AFMD
| $55.6M | ﹤0.01% |
702,878
+168,721
| +32% | +$11M |
|
|
GOOD
2545
Gladstone Commercial Corp
GOOD
$641M
| $55.6M | ﹤0.01% |
2,842,006
+167,907
| +6% | +$3.17M |
|
|
KLRS
2546
Kalaris Therapeutics
KLRS
$92.4M
| $55.5M | ﹤0.01% |
103,177
+24,284
| +31% | +$20.4M |
|
2547
Ribbon Communications
RBBN
$377M
| $55.3M | ﹤0.01% |
6,732,179
+616,448
| +10% | +$5.1M |
|
2548
iShares Gold Trust
IAU
$64.5B
| $55.2M | ﹤0.01% |
1,695,955
+116,516
| +7% | +$3.98M |
|
2549
Seer Inc
SEER
$116M
| $55.1M | ﹤0.01% |
1,102,136
+1,047,418
| +1,914% | +$61.3M |
|
|
AMK
2550
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $55.1M | ﹤0.01% |
2,361,884
+651,218
| +38% | +$15.8M |
|
Similar funds
BlackRock's Q1 2021 Portfolio in Review
As of Q1 2021, BlackRock held 5,453 positions worth $3.4T, up 8.5% from $3.13T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BlackRock's Q1 2021 filing shows 377 new, 3,642 increased, 849 reduced and 151 closed positions. Its largest new stake was Coupang: 38,242,925 shares worth $1.89B. The largest sale was Tiffany & Co., an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2021 buy was Coupang: 38,242,925 shares worth $1.89B.
- BlackRock added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $4.96B increase.
- BlackRock's biggest Q1 2021 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.39B.
- BlackRock fully exited Tiffany & Co. in Q1 2021, selling an estimated $1.46B.
- BlackRock's ten largest holdings make up 17% of its $3.4T portfolio in Q1 2021.
- BlackRock opened 377 new positions and closed 151 in Q1 2021.
- BlackRock's portfolio value rose 8.5% quarter-over-quarter to $3.4T.
Based on BlackRock's 13F filing for Q1 2021, filed 7 May 2021.